[HTML][HTML] Amyloid-beta and tau protein beyond Alzheimer's disease

M Abyadeh, V Gupta, JA Paulo… - Neural Regeneration …, 2024 - journals.lww.com
The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to
play key roles in Alzheimer's disease pathogenesis and are considered the main …

The Role of Cysteine Protease cathepsins B, H, C, and X/Z in neurodegenerative diseases and cancer

V Stoka, O Vasiljeva, H Nakanishi, V Turk - International journal of …, 2023 - mdpi.com
Papain-like cysteine proteases are composed of 11 human cysteine cathepsins, originally
located in the lysosomes. They exhibit broad specificity and act as endopeptidases and/or …

Key genes and biochemical networks in various brain regions affected in Alzheimer's disease

M Abyadeh, N Tofigh, S Hosseinian, M Hasan… - Cells, 2022 - mdpi.com
Alzheimer's disease (AD) is one of the most complicated progressive neurodegenerative
brain disorders, affecting millions of people around the world. Ageing remains one of the …

[HTML][HTML] Apolipoprotein ε in brain and retinal neurodegenerative diseases

M Abyadeh, V Gupta, JA Paulo, S Sheriff… - Aging and …, 2023 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common form of dementia that remains incurable and
has become a major medical, social, and economic challenge worldwide. AD is …

Bromodomains in human-immunodeficiency virus-associated neurocognitive disorders: a model of ferroptosis-induced neurodegeneration

A Sfera, KG Thomas, CV Andronescu, N Jafri… - Frontiers in …, 2022 - frontiersin.org
Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND)
comprise a group of illnesses marked by memory and behavioral dysfunction that can occur …

Common molecular signatures between coronavirus infection and Alzheimer's disease reveal targets for drug development

M Abyadeh, VK Yadav, A Kaya - Journal of Alzheimer's …, 2023 - content.iospress.com
Background: Cognitive decline is a common consequence of COVID-19, and studies
suggest a link between COVID-19 and Alzheimer's disease (AD). However, the molecular …

Advances of computer-aided drug design (CADD) in the development of anti-Azheimer's-disease drugs

Y Niu, P Lin - Drug Discovery Today, 2023 - Elsevier
Highlights•The physiological and pathological pathogenesis of AD are outlined.•The
representative drug candidates for targeted therapy of AD and the binding mode with their …

Toosendanin induces hepatocyte damage by inhibiting autophagic flux via TFEB-mediated lysosomal dysfunction

L Luo, Y Liang, Y Fu, Z Liang, J Zheng, J Lan, F Shen… - Pharmaceuticals, 2022 - mdpi.com
Toosendanin (TSN) is a triterpenoid from the fruit or bark of Melia toosendan Sieb et Zucc,
which has clear antitumor and insecticidal activities, but it possesses limiting hepatotoxicity …

The power of molecular dynamics simulations and their applications to discover cysteine protease inhibitors

IJ dos Santos Nascimento… - Mini Reviews in …, 2024 - benthamdirect.com
A large family of enzymes with the function of hydrolyzing peptide bonds, called peptidases
or cysteine proteases (CPs), are divided into three categories according to the peptide chain …

Smoking Impacts Alzheimer's Disease Progression Through Oral Microbiota Modulation

X Dai, R Liang, M Dai, X Li, W Zhao - Molecular neurobiology, 2024 - Springer
Alzheimer's disease (AD) is an important public health challenge with a limited
understanding of its pathogenesis. Smoking is a significant modifiable risk factor for AD …